AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Mindful-Breath for People With COPD

RecruitingNAAges 50 Years - 80 YearsAllThe University of Hong Kong
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Individuals living with chronic obstructive pulmonary disease (COPD) often suffer from stress and behavioral risks such as physical inactivity. In an attempt to promote healthy behaviors and overall wellbeing among this particular population, this study aims to develop and evaluate a personalized Mindful-Breath intervention combining telehealth technology and mindfulness for COPD patients. This is an assessor-blinded, two-arm exploratory randomized controlled trial with a sequential mixed-method design. A total of 60 participants will be recruited and randomly assigned to either intervention or control group using 1:1 ratio. Intervention group will go through 8 weekly 60-min hybrid group sessions, combining mindfulness-based pulmonary rehabilitation and lifestyle modification. Personalized mindfulness-based lifestyle counselling through instant messages with chat-based support throughout

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age: 50-80 years * Sex: Male or female * Education level: Primary or above * Diagnosis: COPD (Baseline FEV1 \<80% and FEV1/FVC \<70% of predicted normal values) * Severity of COPD: Stage I to IV * Group of COPD: Group B, or E, based on 2024 GOLD guideline (36) * Clinical stability: No acute exacerbation in the past 4 weeks. Patients with recent acute exacerbation in the past 4 weeks will be screened again in subsequent follow-up. * Moderate stress: PSS score โ‰ฅ14 (28) * Access to a mobile device (e.g., a smartphone, tablet, or laptop) with internet connectivity * Ability to read, communicate, and provide written consent in Chinese. Exclusion Criteria: * Engaging in \>60 minutes/week of moderate PA based on American Lung Association guidelines * Recent or ongoing receipt of other pharmacological/behavioral trials within the past 3 months * Contraindications or severe comorbidities that may limit full participation (mental diseases, deafness, limb activity disorder, coronary heart disease, arterial aneurysm, uncontrolled hypertension, pregnancy, etc) * Co-existing respiratory diseases (Asthma/interstitial lung disease/bronchiectasis) or active malignancies * Very severe COPD requiring long-term oxygen therapy or home non-invasive ventilation
๐Ÿ’Š

What it tests

  • Hybrid Mindfulness-Based Group Sessions
  • Ecological Momentary Interventions (EMI)
  • Single General Education on Pulmonary Rehabilitation and Lifestyle Modification Group
  • Activity Monitoring
๐Ÿ“

Where

1 site
School of Nursing, The University of Hong Kong, Hong Kong
Hong Kong, Hong Kong
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy